Literature DB >> 3877937

Interleukin 1 can act as a B-cell growth and differentiation factor.

B L Pike, G J Nossal.   

Abstract

Splenic B lymphocytes specifically reactive to the hapten fluorescein (FLU) were prepared from nonimmune adult mice by affinity fractionation on hapten-gelatin. These FLU-specific B cells were cultured as single cells or in small numbers in 10-microliter wells either in the absence of any feeder, filler, or accessory cell or in the presence of 3T3 fibroblasts acting as filler cells. A selected batch of a "T-cell-independent" antigen, FLU-Ficoll, which induces growth and differentiation only in the presence of lymphokines or cytokines acting as B-cell growth and differentiation factors (BGDF), was used as the antigenic stimulus. It was found that murine interleukin 1 prepared by recombinant DNA technology was an effective, although weak, BGDF when acting with antigen on B cells cultured either under filler cell-free conditions or in the presence of 3T3 cells. When the murine interleukin 1 was used in combination with recombinant human interleukin 2, itself a weak but effective BGDF in the system, an additive effect was observed. The results challenge the notion that interleukin 1 is exclusively or even primarily an activating cytokine. This system, in which pure factors are able to act with specific antigen on single hapten-specific B cells, will prove helpful for the further dissection of the respective roles of the various factors that can act on B cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877937      PMCID: PMC391461          DOI: 10.1073/pnas.82.23.8153

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Sequential use of hapten-gelatin fractionation and fluorescence-activated cell sorting in the enrichment of hapten-specific B llymphocytes.

Authors:  G J Nossal; B L Pike; F L Battye
Journal:  Eur J Immunol       Date:  1978-03       Impact factor: 5.532

3.  Purification to apparent homogeneity of murine interleukin 1.

Authors:  S B Mizel; D Mizel
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

Review 4.  Regulation of B-cell growth and differentiation by soluble factors.

Authors:  M Howard; W E Paul
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

5.  Proliferation and differentiation of single hapten-specific B lymphocytes is promoted by T-cell factor(s) distinct from T-cell growth factor.

Authors:  B L Pike; D L Vaux; I Clark-Lewis; J W Schrader; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

6.  Antibody production by single, hapten-specific B lymphocytes: an antigen-driven cloning system free of filler or accessory cells.

Authors:  D L Vaux; B L Pike; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

7.  Two distinct factors are required for induction of T-cell growth.

Authors:  E L Larsson; N N Iscove; A Coutinho
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

8.  Antigen-induced T cell-replacing factor (TRF). III. Establishment of T cell hybrid clone continuously producing TRF and functional analysis of released TRF.

Authors:  K Takatsu; K Tanaka; A Tominaga; Y Kumahara; T Hamaoka
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

9.  B cell helper factors. II. Synergy among three helper factors in the response of T cell- and macrophage-depleted B cells.

Authors:  H J Liebson; P Marrack; J Kappler
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

10.  Potentiation of the T-lymphocyte response to mitogens. I. The responding cell.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

View more
  20 in total

1.  An analysis of the growth and differentiation of B cells isolated from follicles of the ileal Peyer's patch of sheep.

Authors:  P J Griebel; W C Davis; J D Reynolds
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

Review 2.  Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation.

Authors:  Sujatha Muralidharan; Pranoti Mandrekar
Journal:  J Leukoc Biol       Date:  2013-08-29       Impact factor: 4.962

Review 3.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

4.  Response of neoplasms of B cell lineage to the proliferative effects of B cell growth factor and the phorbol ester TPA.

Authors:  M C Kinney; R D Collins; J Whitlock; J B Cousar; L B Vogler
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

Review 5.  Conjugate vaccines: practice and theory.

Authors:  R S Becker
Journal:  Springer Semin Immunopathol       Date:  1993

6.  Growth modulation of human tumor cells by a growth-inhibiting activity derived from tumorigenic V79 Chinese hamster cells.

Authors:  I Ichinose; S Nakano; T Esaki; T Koga; K Mitsugi; H Yamada; Y Niho
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

7.  T-cell-replacing factor (interleukin 5) induces expression of interleukin 2 receptors on murine splenic B cells.

Authors:  M S Loughnan; K Takatsu; N Harada; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  In vitro production of B cell growth factor and B cell differentiation factor by peripheral blood mononuclear cells and bronchoalveolar lavage T lymphocytes from patients with idiopathic pulmonary fibrosis.

Authors:  M Emura; S Nagai; M Takeuchi; M Kitaichi; T Izumi
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

9.  An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses.

Authors:  James P Phipps; Karen M Haas
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

10.  Efficient production of IgG human monoclonal antibodies by lymphocytes stimulated by lipopolysaccharide, pokeweed mitogen, and interleukin 4.

Authors:  K Yoshinari; K Arai; H Kimura; K Matsumoto; Y Yamaguchi
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-06       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.